Overall Survival with Ribociclib plus Endocrine Therapy in Breast CancerSeock‐Ah Im, Debu Tripathy, Keun-Seok Lee et al.|New England Journal of Medicine|2019Cited by 1k
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trialDebu Tripathy, Yen‐Shen Lu, Seock‐Ah Im et al.|The Lancet Oncology|2018Cited by 1k
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYen‐Shen Lu, Ching-Shih Chen|Hepatology|2007Cited by 91
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to TamoxifenI‐Chun Chen, Yen‐Shen Lu|Scientific Reports|2017Cited by 33